Dear Editor
The paper by Buetti et al. [1] regarding the prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients presented a fascinating finding. In this Swiss cohort, the presence of diabetes mellitus (DM) in critically ill patients proved to be a risk factor for prolonged SARS-CoV-2 RNA. In a recent work, we assessed clinical and demographic risk factors for prolonged viral RNA shedding and time to achieve the cessation of viral RNA shedding (CVS) in 251 patients with COVID-19 based on nasopharyngeal samples only [2].
We identified 34 (14%) patients with DM (Table 1). These patients were older (60 years [IQR 15.5] vs. 50 years [IQR 28]; p < 0.001) and had a higher frequency of comorbidities such as obesity, coronary artery disease, chronic obstructive pulmonary disease, and heart failure (p < 0.01) when compared to patients without DM. Patients with DM were more frequently hospitalized (61.8 vs. 18.9%; p < 0.001) than patients without DM. Dyspnea, diarrhea, and dizziness were more frequently seen in patients with DM (p < 0.01) at the time of diagnosis. Despite these differences, there was no difference in time to achieve CVS when compared to patients with and without DM (24 days (IQR 11.8) vs. 23 days (IQR 12); p = 0.591). This is best observed in Fig. 1. Interestingly, dizziness was more commonly reported at the time of CVS in patients with DM. DM was not associated with prolonged viral RNA shedding in a univariate regression model (p = 0.49).
In contrast to Buetti et al., our findings suggest that patients with DM do not show prolonged RNA viral shedding based on nasopharyngeal sampling despite older age and a higher frequency of comorbidities. DM has been described by Wang et al. [3] as a risk factor for viral RNA detection in both nasopharyngeal and sputum samples. Nevertheless, the presence of DM was not associated with prolonged shedding in their sample either. The determination of whether prolonged viral RNA shedding in lower respiratory samples represents a particular phenomenon of patients with DM or other immunocompromising states requires additional research and collaboration that combines different types of samples, timelines, and clinical characteristics.
References
N. Buetti, P. Trimboli, T. Mazzuchelli, et al. Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients. Endocrine (2020). https://doi.org/10.1007/s12020-020-02465-4
C.C. Campioli, E.C. Cevallos, M. Assi, R. Patel, M.J. Binnicker, J.C. O’Horo, Clinical predictors and timing of cessation of viral RNA shedding in patients with COVID-19. J. Clin. Virol. 130, 104577 (2020). https://doi.org/10.1016/j.jcv.2020.104577
K. Wang, X. Zhang, J. Sun, et al. Differences of severe acute respiratory syndrome coronavirus 2 shedding duration in sputum and nasopharyngeal swab specimens among adult inpatients with coronavirus disease 2019. Chest (2020). https://doi.org/10.1016/j.chest.2020.06.015
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
J.C.O. has provided consulting services for Elsevier, Inc and Bates College.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Cano, E., Corsini Campioli, C. & O’Horo, J.C. Nasopharyngeal SARS-CoV-2 viral RNA shedding in patients with diabetes mellitus. Endocrine 71, 26–27 (2021). https://doi.org/10.1007/s12020-020-02516-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-020-02516-w